Floatz logo

Omeprazole

Lymphoma

European Organisation for Research and Treatment of Cancer - EORTCSmall moleculePhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
65/ 100

Competitive context

289 Active assets in the Lymphoma cohort.

Asset / SponsorPhaseRating
VINBLASTINE
Intensity Therapeutics, Inc.
Phase 4BBB
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
The Lymphoma Academic Research Organisation
Phase 4BBB
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
BLEOMYCIN
Shandong Provincial Hospital
Phase 4BB
PREDNISONE TABLETS
Beth Israel Deaconess Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

Omeprazole is also rated in:

morbid obesityDormant
BB
Indicative ·
70 / 100
View asset →
Helicobacter Pylori InfectionDormant
BB
Indicative ·
68 / 100
View asset →
primary mediastinal large B-cell lymphomaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →